Q32 Bio (QTTB) Other Non-Current Liabilities (2023 - 2025)

Q32 Bio's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $55.0 million for Q3 2025.

• In Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $55.0 million; the TTM figure through Sep 2025 stood at $55.0 million (changed 0.0% YoY), while the FY2024 annual figure was $55.0 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities was $55.0 million for Q3 2025 at Q32 Bio, roughly flat from $55.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $55.1 million in Q1 2024 to a low of $55.0 million in Q4 2023.
• Historically, Other Non-Current Liabilities has averaged $55.0 million across 3 years, with a median of $55.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities changed 0.0% in 2024, then fell 0.21% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $55.0 million (Q3 2025), $55.0 million (Q2 2025), and $55.0 million (Q1 2025), per Business Quant data.